Powered by
Lattice Biologics Ltd. Reports First Quarter 2017 Highlights
Mar 1, 2017 - Marketwire (Canada)

SCOTTSDALE, ARIZONA -- (Marketwired) -- 03/01/17 -- Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCQB:LBLTF) ("Lattice Biologics" or the "Company") announces financial results for the first quarter ended December 31, 2016:

Q1 2017 Business Update:

The Company remains focused on raising additional capital to: assist with its working capital constraint; fulfill open purchase orders; launch the Company's new product lines; and support R&D efforts. Appropriate working capital conditions wi

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox